Characterization of the Somatomedin-C/Insulin-Like Growth Factor I (SM-C/IGF-I) Receptor on Cultured Human Fibroblast Monolayers: Regulation of Receptor Concentrations by SM-C/IGF-I and Insulin*
- 1 September 1982
- journal article
- research article
- Published by The Endocrine Society in Journal of Clinical Endocrinology & Metabolism
- Vol. 55 (3) , 434-440
- https://doi.org/10.1210/jcem-55-3-434
Abstract
We have characterized 125I-labeled somatomedin-C/insulin-like growth factor 1 ([125I]SM-C/IGF-I) binding to cultured human fibroblast monolayers and have investigated the modulation of receptor concentrations by SM-C/IGF-I and insulin. Specific binding of [125I]SM-C/IGF-I to confluent monolayers at 15 C reached a steady state in 2.5 h and averaged 11.37 ± 0.71% (mean ± SEM)/1.5 × 106 cells. At 30 C, binding occurred more rapidly, peaking at 30 min, but averaged only 4%. Binding was reversible at both temperatures, and degradation of radioligand by fibroblast monolayers was negligible. Half-maximal inhibition of [125I]SM-C/IGF-I binding was observed at SM-C/IGF-I concentrations of 7 ng/ml. Compared to SM-C/IGF-I, the relative potencies of other hormones was: IGF-II, 1:10; multiplication-stimulating activity, 1:17, porcine insulin, 1:300; porcine proinsulin, 1:1000; and human GH nonreactive. Scatchard analysis was consistent with a single class of receptors, with a Ka of 1.07 × 109 M−1 and 20,000 sites/cell. Preincubation of fibroblast monolayers with either SM-C/IGF-I or insulin resulted in a time- and concentration-dependent reduction in the binding of [125I]SM-C/IGF-I. Twenty-hour preexposure of monolayers to 2 × 10−8 M SM-C/IGF-I induced a 50% decrease in the binding of [125I]SM-C/IGF-I, while preincubation with 10−7 M SM-C/IGF-I resulted in a 70% decrease in binding. Similarly, binding was reduced 34% and 45% after preincubation with 10−7 or 10−6 M insulin, respectively. Half-maximal reduction in binding required preincubation for 10 h at 37 C, and maximal decreases in binding occurred after 20 h of preincubation with either SM-C/IGF-I or insulin. These studies thus demonstrate that: 1) cultured human fibroblasts possess highly specific SM-C/IGF-I receptors which may be studied directly in cell monolayers, and 2) SM-C/IGF-I receptor concentrations are directly modulated by ambient concentrations of either SM-C/IGF-I or insulin, thus emphasizing the structural and functional homology of these peptides.Keywords
This publication has 19 references indexed in Scilit:
- Evaluation of Acromegaly by Radioimmunoassay of Somatomedin-CNew England Journal of Medicine, 1979
- Primary defect of insulin receptors in skin fibroblasts cultured from an infant with leprechaunism and insulin resistance.Proceedings of the National Academy of Sciences, 1979
- Stoichiometric binding and regulation of insulin receptors on human diploid fibroblasts using physiologic insulin levels.Journal of Biological Chemistry, 1979
- Increased Somatomedin Receptor Sites in Newborn Circulating Mononuclear Cells*Journal of Clinical Endocrinology & Metabolism, 1979
- The syndromes of primary hormone resistanceMetabolism, 1979
- Insulin‐Like Growth Factors I and II: Some Biological Actions and Receptor Binding Characteristics of Two Purified Constituents of Nonsuppressible Insulin‐Like Activity of Human SerumEuropean Journal of Biochemistry, 1978
- Estimation of Somatomedin-C Levels in Normals and Patients with Pituitary Disease by RadioimmunoassayJournal of Clinical Investigation, 1977
- Identification of a Receptor for Somatomedin-Like Polypeptides in Human Fibroblasts*Journal of Clinical Endocrinology & Metabolism, 1977
- Specific 125I-somatomedin receptor on circulating human mononuclear cellsBiochemical and Biophysical Research Communications, 1977
- Polypeptides with nonsuppressible insulin-like and cell-growth promoting activities in human serum: isolation, chemical characterization, and some biological properties of forms I and II.Proceedings of the National Academy of Sciences, 1976